| Secondary |
| Product Used For Unknown Indication |
60.8% |
| Drug Use For Unknown Indication |
9.3% |
| Asthma |
6.4% |
| Bronchial Hyperreactivity |
4.9% |
| Hypertension |
4.9% |
| Chronic Obstructive Pulmonary Disease |
4.4% |
| Muscle Spasms |
2.0% |
| Aspergillosis |
1.5% |
| Hypothyroidism |
1.0% |
| Strongyloidiasis |
1.0% |
| Anxiety |
0.5% |
| Anxiety Disorder |
0.5% |
| Atrial Fibrillation |
0.5% |
| Depression |
0.5% |
| Diabetic Neuropathy |
0.5% |
| Gastrooesophageal Reflux Disease |
0.5% |
| Rhinitis |
0.5% |
| Type 2 Diabetes Mellitus |
0.5% |
|
| Vestibular Disorder |
20.0% |
| Drug Ineffective |
10.0% |
| Urinary Retention |
10.0% |
| Vomiting |
10.0% |
| Completed Suicide |
5.0% |
| Hypospadias |
5.0% |
| Laryngospasm |
5.0% |
| Non-hodgkin's Lymphoma |
5.0% |
| Resuscitation |
5.0% |
| Surgery |
5.0% |
| Toxicity To Various Agents |
5.0% |
| Vision Blurred |
5.0% |
| Weight Decreased |
5.0% |
| Weight Increased |
5.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
34.1% |
| Product Used For Unknown Indication |
18.3% |
| Pain |
10.9% |
| Chronic Obstructive Pulmonary Disease |
3.8% |
| Asthma |
3.4% |
| Prophylaxis |
3.3% |
| Depression |
3.1% |
| Hypertension |
2.8% |
| Myeloma Recurrence |
2.6% |
| Anxiety |
2.4% |
| Behcet's Syndrome |
2.0% |
| Nausea |
1.8% |
| Vitamin Supplementation |
1.8% |
| Breast Cancer |
1.7% |
| Acute Coronary Syndrome |
1.4% |
| Infection Prophylaxis |
1.4% |
| Colony Stimulating Factor Prophylaxis |
1.3% |
| Non-small Cell Lung Cancer |
1.3% |
| Reflux Gastritis |
1.3% |
| Gastrooesophageal Reflux Disease |
1.1% |
|
| Vision Blurred |
10.8% |
| Wheezing |
10.8% |
| Pneumonia |
9.2% |
| Chronic Obstructive Pulmonary Disease |
6.2% |
| Pyrexia |
6.2% |
| Thrombocytopenia |
6.2% |
| Death |
4.6% |
| Pleural Effusion |
4.6% |
| Pulmonary Embolism |
4.6% |
| Vomiting |
4.6% |
| Weight Decreased |
4.6% |
| Activated Partial Thromboplastin Time Prolonged |
3.1% |
| Asthenia |
3.1% |
| Hyponatraemia |
3.1% |
| Malignant Neoplasm Progression |
3.1% |
| Myopathy |
3.1% |
| Nephrotic Syndrome |
3.1% |
| Neutropenia |
3.1% |
| Pericardial Effusion |
3.1% |
| Proteinuria |
3.1% |
|
| Interacting |
| Hiv Infection |
47.1% |
| Product Used For Unknown Indication |
41.2% |
| Asthma |
5.9% |
| Intervertebral Disc Protrusion |
5.9% |
|
| Plasmablastic Lymphoma |
50.0% |
| Potentiating Drug Interaction |
50.0% |
|
